开发用于治疗转移的有效免疫治疗方案的临床前方法。 - Suppr | 超能文献

Preclinical approaches to the development of effective immunotherapeutic protocols for the treatment of metastasis.

作者信息

Talmadge J E

出版信息

Prog Clin Biol Res. 1986;212:197-215.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Preclinical approaches to the development of effective immunotherapeutic protocols for the treatment of metastasis.开发用于治疗转移的有效免疫治疗方案的临床前方法。

Prog Clin Biol Res. 1986;212:197-215.

2

Tumor models to investigate the therapeutic efficiency of immunomodulators.用于研究免疫调节剂治疗效果的肿瘤模型。

Behring Inst Mitt. 1984 May(74):219-29.

3

The NCI preclinical screen of biological response modifiers.美国国立癌症研究所生物反应调节剂的临床前筛选

Behring Inst Mitt. 1984 May(74):189-94.

4

[Effects of interleukin-2 and lymphokine-activated killer cells on cell cultures and on transplanted tumors (nude mouse) of human pancreatic carcinomas].白细胞介素-2和淋巴因子激活的杀伤细胞对人胰腺癌细胞培养物及移植瘤（裸鼠）的影响

Beitr Infusionther Klin Ernahr. 1987;18:261-5.

5

Immunomodulation and antitumor effects of MVE-2 in mice.MVE-2对小鼠的免疫调节及抗肿瘤作用

J Biol Response Mod. 1984 Dec;3(6):634-52.

6

Implementation of an RIL-2/LAK cell clinical trial: a nursing perspective.一项RIL-2/LAK细胞临床试验的实施：护理视角

Oncol Nurs Forum. 1986 Nov-Dec;13(6):31-6.

7

Immunotherapy of cancer with lymphokine-activated killer cells and recombinant interleukin-2.用淋巴因子激活的杀伤细胞和重组白细胞介素-2进行癌症免疫治疗。

Surgery. 1985 Sep;98(3):437-44.

8

The preclinical screening laboratory: evaluation of immunomodulatory and therapeutic properties of biological response modifiers.

Cancer Treat Rep. 1986 Jan;70(1):171-82.

9

Clinical trials with IL-2.

Oncol Nurs Forum. 1986 Nov-Dec;13(6):25-9.

10

Angiosarcoma of the scalp treated with curative radiotherapy plus recombinant interleukin-2 immunotherapy.采用根治性放疗加重组白细胞介素-2免疫疗法治疗头皮血管肉瘤。

Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1446-53. doi: 10.1016/j.ijrobp.2004.08.008.

引用本文的文献

1

Aminopeptidase-N/CD13 (EC 3.4.11.2) inhibitors: chemistry, biological evaluations, and therapeutic prospects.氨肽酶-N/CD13（EC 3.4.11.2）抑制剂：化学、生物学评价及治疗前景

Med Res Rev. 2006 Jan;26(1):88-130. doi: 10.1002/med.20044.

2

Inhibition of spontaneous pulmonary metastases of Lewis lung carcinoma by oral treatment with Respivax and Broncho-Vaxom.通过口服Respivax和支气管疫苗抑制Lewis肺癌的自发性肺转移。

Cancer Immunol Immunother. 1991;33(5):307-13. doi: 10.1007/BF01756595.